ProstaLund signs new agreement with existing customer

MAR

ProstaLund and Urogyn Sverige AB have signed a new agreement regarding disposables for CoreTherm® treatments. The new agreement guarantees revenues of about SEK 1.6 million over the next twelve months. The first delivery under the new agreement will take place in May.

ProstaLund and Urogyn Sverige AB have today signed a new agreement regarding disposables used in CoreTherm® treatments. The agreement extends over twelve months, with an option to extend. The order value is SEK 1.6 million during the contract period. The agreement replaces the previous agreement with Urogyn Sverige AB. Previous agreement were worth about SEK 0.9 million per year.

"This is the second agreement with significantly increased guaranteed volumes we sign within a month. The fact that we are now entering into yet another agreement with a clinic that wants to scale up its CoreTherm® business means that we are taking a much stronger grip on the BPH/BPE market in Sweden and especially the Stockholm area. Both new agreements prove that CoreTherm® delivers good results to patients. For ProstaLund, the agreements mean that we will have continuity in terms of both orders and cash flow, which means that we can continue our pace of expansion according to plan", says CEO Johan Wennerholm in a comment.

Datum 2022-05-10, kl 15:40
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!